Market Cap 8.73B
Revenue (ttm) 5.00B
Net Income (ttm) 493.20M
EPS (ttm) N/A
PE Ratio 13.52
Forward PE 12.37
Profit Margin 9.85%
Debt to Equity Ratio 0.18
Volume 1,773,500
Avg Vol 932,924
Day's Range N/A - N/A
Shares Out 112.89M
Stochastic %K 15%
Beta 0.51
Analysts Strong Sell
Price Target $104.20

Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, and media service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES24, a set of embedded GenAI-driven assistants powered by the amAIz platform designed to empower service providers to transform their business; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes a...

Industry: Software - Infrastructure
Sector: Technology
Phone: 314 212 7000
Fax: 314 212 7500
Address:
625 Maryville Centre Drive, Suite 200, Saint Louis, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:29 AM
$DOX is currently trading at $77.74, showing a bearish market context as indicated by an RSI of 26.49, which suggests the stock is oversold. The 30-day moving average (MA30) at $82.74 and the 50-day moving average (MA50) at $83.02 are both above the current price, reinforcing a downward trend. The 60-day high of $88.46 and low of $75.35 indicates a trading range, with the current price closer to the low. Directional bias is bearish due to the oversold RSI and the position of MAs. Suggested trade plan: - Entry: $77.50 (slightly below current price to confirm momentum) - Stop: $76.50 (to limit potential losses) - Target 1: $80.00 (near MA30) - Target 2: $82.00 (near MA50) Monitor for any reversal signals as the stock approaches the lower end of its recent range. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:02 AM
$DOX: The current market context shows a last close of $76.91, indicating a bearish sentiment as the price is near the 60D low of $75.35. The RSI at 26.6 suggests that the stock is oversold, which could indicate a potential reversal or bounce. However, the stock is trading below both the 30-day MA of 82.89 and the 50-day MA of 83.19, reinforcing a bearish trend. Directional bias is bearish in the short term due to the price action below moving averages, but the oversold RSI could lead to a short-term recovery. Suggested entry is at $76.50, with a stop loss at $75.00 to limit potential losses. Targets can be set at $80.00 for a conservative approach and $82.00 for a more aggressive target, aligning with the 30-day MA. Monitor for price action around these levels to reassess the trade. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
moneymavens
moneymavens Nov. 13 at 5:38 PM
$DOX rumor making the rounds is t-mobile with its great earnings might just aquire dox and fold into there international empire.. makes sense and the buyout pays for itself as book value for dox is over 33$ a share .. interesting
1 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 1:01 PM
Wolfe Research has updated their rating for Amdocs ( $DOX ) to Peer Perform.
0 · Reply
moneymavens
moneymavens Nov. 13 at 11:54 AM
$DOX $31.38 book value X 3x is average valuation price or $94.00 price target on DOX..
0 · Reply
moneymavens
moneymavens Nov. 13 at 11:48 AM
$DOX im thinking this management cant be this detached to see the stock dive to a 3 year low after great earnings and they might be setting the stage for a weekend announcement where they put themselves on the block for bidders or they ink a deal with a major technology company. If nothing done a 5 year low is imminent.. stay tuned 😉
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:09 AM
$DOX is currently trading at $83.96, showing a neutral RSI of 50.89, indicating a lack of momentum in either direction. The price is above the 30-day moving average (MA30) of $83.19 and the 50-day moving average (MA50) of $83.49, suggesting a potential bullish bias as it indicates short-term strength. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $88.46 and low of $80.35 establishes a range, with the current price closer to the upper bound, which could indicate resistance. Suggested trade plan: - Entry: $84.20 (above current close to confirm upward momentum) - Stop: $82.50 (below recent support) - Target 1: $86.00 (near the 60D high) - Target 2: $88.00 (slightly below the 60D high for profit-taking) Monitor for any changes in RSI or moving averages for adjustments. https://privateprofiteers.com
0 · Reply
SerenyaX
SerenyaX Nov. 12 at 6:24 PM
$DOX This is my checklist: Mainz Biomed beats on AA ~82% (vs 43%/13%) and holds ~97/97 CRC with ~100% HGD. Maxim primed institutions, GARPS primed clinicians, MEDICA closes distribution and lab pilots in EU/UK/CH. Hit two deals and the $14 price target becomes reasonable, not optimistic.
0 · Reply
InfiniteProfitTrader
InfiniteProfitTrader Nov. 12 at 5:41 PM
$DOX had to hop in here!
0 · Reply
moneymavens
moneymavens Nov. 12 at 4:39 PM
$DOX I expect a major partnership announcement by next week .. this is a stop loss walk down and will lead to a massive rally.. put options are dead with no volume and that signals this is a short cover ahead of a high push.. stay tuned 😉
0 · Reply
Latest News on DOX
Amdocs Limited (DOX) Q4 2025 Earnings Call Transcript

Nov 11, 2025, 8:51 PM EST - 2 days ago

Amdocs Limited (DOX) Q4 2025 Earnings Call Transcript


Amdocs Limited Reports Fourth Quarter Results for Fiscal 2025

Nov 11, 2025, 4:01 PM EST - 3 days ago

Amdocs Limited Reports Fourth Quarter Results for Fiscal 2025


RADCOM Appoints Hod Cohen as Chief Financial Officer

Oct 30, 2025, 7:00 AM EDT - 15 days ago

RADCOM Appoints Hod Cohen as Chief Financial Officer

RDCM


Amdocs: In-Line Q3 Supports A Hold

Aug 11, 2025, 2:57 AM EDT - 3 months ago

Amdocs: In-Line Q3 Supports A Hold


Amdocs Limited (DOX) Q3 2025 Earnings Call Transcript

Aug 8, 2025, 2:57 PM EDT - 3 months ago

Amdocs Limited (DOX) Q3 2025 Earnings Call Transcript


Amdocs Limited Reports Third Quarter Fiscal 2025 Results

Aug 6, 2025, 4:01 PM EDT - 3 months ago

Amdocs Limited Reports Third Quarter Fiscal 2025 Results


Amdocs Announces Q4F25 Investor Conference Schedule

Jul 8, 2025, 8:00 AM EDT - 4 months ago

Amdocs Announces Q4F25 Investor Conference Schedule


Amdocs Limited (DOX) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:20 PM EDT - 6 months ago

Amdocs Limited (DOX) Q2 2025 Earnings Call Transcript


Amdocs Limited Reports Second Quarter Fiscal 2025 Results

May 7, 2025, 4:01 PM EDT - 6 months ago

Amdocs Limited Reports Second Quarter Fiscal 2025 Results


Amdocs Announces Q3F25 Investor Conference Schedule

Apr 9, 2025, 4:05 PM EDT - 7 months ago

Amdocs Announces Q3F25 Investor Conference Schedule


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:29 AM
$DOX is currently trading at $77.74, showing a bearish market context as indicated by an RSI of 26.49, which suggests the stock is oversold. The 30-day moving average (MA30) at $82.74 and the 50-day moving average (MA50) at $83.02 are both above the current price, reinforcing a downward trend. The 60-day high of $88.46 and low of $75.35 indicates a trading range, with the current price closer to the low. Directional bias is bearish due to the oversold RSI and the position of MAs. Suggested trade plan: - Entry: $77.50 (slightly below current price to confirm momentum) - Stop: $76.50 (to limit potential losses) - Target 1: $80.00 (near MA30) - Target 2: $82.00 (near MA50) Monitor for any reversal signals as the stock approaches the lower end of its recent range. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:02 AM
$DOX: The current market context shows a last close of $76.91, indicating a bearish sentiment as the price is near the 60D low of $75.35. The RSI at 26.6 suggests that the stock is oversold, which could indicate a potential reversal or bounce. However, the stock is trading below both the 30-day MA of 82.89 and the 50-day MA of 83.19, reinforcing a bearish trend. Directional bias is bearish in the short term due to the price action below moving averages, but the oversold RSI could lead to a short-term recovery. Suggested entry is at $76.50, with a stop loss at $75.00 to limit potential losses. Targets can be set at $80.00 for a conservative approach and $82.00 for a more aggressive target, aligning with the 30-day MA. Monitor for price action around these levels to reassess the trade. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
moneymavens
moneymavens Nov. 13 at 5:38 PM
$DOX rumor making the rounds is t-mobile with its great earnings might just aquire dox and fold into there international empire.. makes sense and the buyout pays for itself as book value for dox is over 33$ a share .. interesting
1 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 1:01 PM
Wolfe Research has updated their rating for Amdocs ( $DOX ) to Peer Perform.
0 · Reply
moneymavens
moneymavens Nov. 13 at 11:54 AM
$DOX $31.38 book value X 3x is average valuation price or $94.00 price target on DOX..
0 · Reply
moneymavens
moneymavens Nov. 13 at 11:48 AM
$DOX im thinking this management cant be this detached to see the stock dive to a 3 year low after great earnings and they might be setting the stage for a weekend announcement where they put themselves on the block for bidders or they ink a deal with a major technology company. If nothing done a 5 year low is imminent.. stay tuned 😉
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:09 AM
$DOX is currently trading at $83.96, showing a neutral RSI of 50.89, indicating a lack of momentum in either direction. The price is above the 30-day moving average (MA30) of $83.19 and the 50-day moving average (MA50) of $83.49, suggesting a potential bullish bias as it indicates short-term strength. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $88.46 and low of $80.35 establishes a range, with the current price closer to the upper bound, which could indicate resistance. Suggested trade plan: - Entry: $84.20 (above current close to confirm upward momentum) - Stop: $82.50 (below recent support) - Target 1: $86.00 (near the 60D high) - Target 2: $88.00 (slightly below the 60D high for profit-taking) Monitor for any changes in RSI or moving averages for adjustments. https://privateprofiteers.com
0 · Reply
SerenyaX
SerenyaX Nov. 12 at 6:24 PM
$DOX This is my checklist: Mainz Biomed beats on AA ~82% (vs 43%/13%) and holds ~97/97 CRC with ~100% HGD. Maxim primed institutions, GARPS primed clinicians, MEDICA closes distribution and lab pilots in EU/UK/CH. Hit two deals and the $14 price target becomes reasonable, not optimistic.
0 · Reply
InfiniteProfitTrader
InfiniteProfitTrader Nov. 12 at 5:41 PM
$DOX had to hop in here!
0 · Reply
moneymavens
moneymavens Nov. 12 at 4:39 PM
$DOX I expect a major partnership announcement by next week .. this is a stop loss walk down and will lead to a massive rally.. put options are dead with no volume and that signals this is a short cover ahead of a high push.. stay tuned 😉
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Nov. 12 at 1:32 PM
$DOX 💻 1H Levels Price: $83.60 Support: $81.40 Resistance: $85.80 Steady structure—range intact near current levels.
0 · Reply
Bigbiydaddytrader
Bigbiydaddytrader Nov. 12 at 1:01 PM
$DOX b of a just lowered PT expect many more downgrades today and flush under 80
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 12:58 PM
Stifel has adjusted their stance on Amdocs ( $DOX ), setting the rating to Buy with a target price of 100 → 97.
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 12:18 PM
$DOX shines with a Q4 earnings beat, but what's the outlook? 🤔 Amdocs reported non-GAAP EPS of $1.83, surpassing estimates, yet revenues fell 9% YoY on a reported basis due to phasing out certain activities. Managed services grew 3.7%, and backlog increased to $4.19B. Discover Amdocs' full fiscal 2026 guidance and potential growth here 👉 https://www.zacks.com/stock/news/2789715/amdocs-q4-earnings-surpass-estimates-revenues-decline-yy?cid=sm-stocktwits-2-2789715-body-20629&ADID=SYND_STOCKTWITS_TWEET_2_2789715_BODY_20629
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 11:58 AM
B of A Securities updates rating for Amdocs ( $DOX ) to Buy, target set at 100 → 97.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Nov. 12 at 11:31 AM
WATCHLIST NOV 12 2025 $CMND Clearmind Medicine Announces CNIPA Publication Of Patent For MEAI Compound In Depression Treatment $DOX Amdocs Signs Agreement With Vivo To Deliver OSS Project Modernization To Deploy Cloud-Native, Microservices-Based Release Of Service Orchestration, Service Activation $REPL Replimune Group shares are trading higher after the company announced it presented biomarker data and updated clinical data from the IGNYTE clinical trial of RP1 plus nivolumab. $TTE TotalEnergies And Google Have Signed A 15-year Power Purchase Agreement To Supply Google With A Total Volume Of 1.5 TWh Of Certified Renewable Electricity $IBM At The Annual Quantum Developer Conference, IBM Unveils Fundamental Progress On Its Path To Delivering Quantum Advantage By The End Of 2026 And Fault-tolerant Quantum Computing By 2029
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 11:18 AM
$DOX beat on earnings but revenue slipped year over year — mixed signals for investors. EPS came in above expectations, but the top line contracted compared to last year, raising questions about growth momentum. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2789715/amdocs-q4-earnings-surpass-estimates-revenues-decline-yy?cid=sm-stocktwits-2-2789715-teaser-20623&ADID=SYND_STOCKTWITS_TWEET_2_2789715_TEASER_20623
0 · Reply
Bigbiydaddytrader
Bigbiydaddytrader Nov. 12 at 2:59 AM
$DOX will flush in morning/all week
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:45 AM
$DOX is currently trading at $83.96, showing a neutral RSI of 50.89, indicating a lack of momentum in either direction. The price is above the 30-day moving average (MA30) of $83.19 and the 50-day moving average (MA50) of $83.49, suggesting a potential bullish bias as it indicates short-term strength. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $88.46 and low of $80.35 establishes a range, with the current price closer to the upper bound, which could indicate resistance. Suggested trade plan: - Entry: $84.20 (above current close to confirm upward momentum) - Stop: $82.50 (below recent support) - Target 1: $86.00 (near the 60D high) - Target 2: $88.00 (slightly below the 60D high for profit-taking) Monitor for any changes in RSI or moving averages for adjustments. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Nov. 12 at 1:45 AM
$DOX reported 1.83 EPS and 1,150 revenue for Q4. http://www.estimize.com/intro/dox?chart=historical&metric_name=eps&utm_content=DOX&utm_med
0 · Reply
moneymavens
moneymavens Nov. 11 at 9:50 PM
$DOX look for upgrades and reiterating of 100 to 110 price targets.. use this time before 5pm est conf call as a gift entrance
0 · Reply
moneymavens
moneymavens Nov. 11 at 9:48 PM
$DOX massive agreements being announced and inked .. dox and lumn is beyond huge as lumn is in bed with everyone and now dox is too
0 · Reply